Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Epi-kal2
Drug ID BADD_D00779
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID Not Available
MeSH ID Not Available
PubChem ID 44201343
TTD Drug ID Not Available
NDC Product Code Not Available
UNII Not Available
Synonyms Not Available
Chemical Information
Molecular Formula C305H448N88O91S8
CAS Registry Number Not Available
SMILES CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NCC(=O)NCC(=O)NC(CS)C(=O)NC(CCC(=O)O)C(=O)N CC(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC2 =CC=CC=C2)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC C(=O)O)C(=O)NC(CS)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCSC)C(=O)NC(CS)C(=O)NC(C( C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(= O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CS)NC(=O)C(CCC(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) O)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C(C)CC)NC(=O)C(CC(=O)N)NC(=O)C(CC5=CC=CC=C5)NC(=O )C(CC6=CC=CC=C6)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C(CCCNC(=N)N)NC(=O)C9CCCN9C(=O) C(CC1=CN=CN1)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CS)NC(=O)C1CCCN1C(=O )CNC(=O)C(CC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CC1=CC=CC=C1)N C(=O)C(C)NC(=O)C(CS)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CC1=CN=CN1)NC(=O)C(C CSC)NC(=O)C(C)NC(=O)C(CCC(=O)O)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain upper07.01.05.003--
Anaphylactic shock10.01.07.002; 24.06.02.004---
Asthenia08.01.01.001---
Body temperature increased13.15.01.001---
Diarrhoea07.02.01.001--
Erythema23.03.06.001---
Fatigue08.01.01.002--
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Injection site reaction08.02.03.014; 12.07.03.015--
Nasopharyngitis11.01.13.002; 22.07.03.002---
Nausea07.01.07.001--
Pain08.01.08.004--
Pruritus23.03.12.001--
Upper respiratory tract infection11.01.13.009; 22.07.03.011--
Urticaria10.01.06.001; 23.04.02.001--
Vomiting07.01.07.003--
Contusion12.01.06.001; 15.03.05.007; 23.03.11.002; 24.07.06.001--
The 1th Page    1    Total 1 Pages